SUMMARY OF SYNTHETIC CANNABINOID BILLS

Similar documents
SYNTHETIC CANNABINOID BILLS, STATUTES & REGULATIONS

SYNTHETIC CANNABINOID BILLS, STATUTES & REGULATIONS

2012 Medicaid and Partnership Chart

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

2018 HPV Legislative Report Card

ACEP National H1N1 Preparedness Survey Results

Obesity Trends:

National Deaf Center on Postsecondary Outcomes. Data Interpretation Guide for State Reports: FAQ

States with Authority to Require Nonresident Pharmacies to Report to PMP

Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers

Percent of U.S. State Populations Covered by 100% Smokefree Air Laws April 1, 2018

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

Instant Drug Testing State Law Guide

MAKING WAVES WITH STATE WATER POLICIES. Washington State Department of Health

Medical Advisory Board. reviews medical issues for licensure regarding individual drivers. medical conditions. not specified. reporting encouraged,

Responses to a 2017 Survey on State Policies Regarding Community Health Workers: Home Visiting to Improve the Home Environment

Georgina Peacock, MD, MPH

Cirrhosis and Liver Cancer Mortality in the United States : An Observational Study Supplementary Material

Medical Marijuana Responsible for Traffic Fatalities Alfred Crancer, B.S., M.A.; Phillip Drum, Pharm.D.

It's tick time again! Recognizing black-legged (deer ticks) and measuring the spread of Lyme disease

The Rural Health Workforce. Policy Brief Series. Data and Issues for Policymakers in: Washington Wyoming Alaska Montana Idaho

Average Number Citations per Recertification Survey

Forensic Patients in State Hospitals:

STATE RANKINGS REPORT NOVEMBER mississippi tobacco data

Methamphetamines: A National and State Crisis. Research Brief. Prepared by

CDC activities with Autism Spectrum Disorders

Youth and Adult Marijuana Use

The Chiropractic Pediatric CE Credit Program with Emphasis on Autism

Quarterly Hogs and Pigs

Quarterly Hogs and Pigs

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

Health Care Reform: Colorectal Cancer Screening Expansion, Before and After the Affordable Care Act (ACA)

Plan Details and Rates. Monthly Premium Rate Schedule

Contents. Introduction. Acknowledgments. 1 Assisted Reproduction and the Diversity of the Modern Family 1. 2 Intrauterine Insemination 31.

Health Care Reform: Colorectal Cancer Screening Disparities, Before and After the Affordable Care Act (ACA)

Analysis of State Medicaid Agency Performance in Relation to Incentivizing the Provision of H1N1 Immunizations to Eligible Populations

West Nile virus and other arboviral activity -- United States, 2013 Provisional data reported to ArboNET Tuesday, January 7, 2014

PETITION FOR DUAL MEMBERSHIP

Medical Marijuana

DEPARTMENT OF DEFENSE (AFHSB)

CDC activities Autism Spectrum Disorders

Opioid Deaths Quadruple Since 1999

AUL s 2014 Life List

October 3, Dear Representative Hensarling:

If you suspect Fido's owner is diverting prescription pain meds meant for the pet, checking your state's drug monitoring database may not help

April 25, Edward Donnell Ivy, MD, MPH

-Type of immunity that is more permanent (WBC can Remember)

The 2004 National Child Count of Children and Youth who are Deaf-Blind

DEPARTMENT OF DEFENSE (AFHSB)

Hawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB) Seasonal Influenza Surveillance Summary Northern Command -- Week 17 (22 Apr 28 Apr 2018)

The Healthy Indiana Plan

Overview of the States Pesticide Registration Process AAPCO Laboratory Committee

DEPARTMENT OF DEFENSE (AFHSB)

Autism Activities at CDC: The Public Health Model

Model Performance Evaluation Program (MPEP) HIV Rapid Testing Survey: Report of Sample Shipment Results, September 2009

Bryan M. Haynes, Esq. Partner, Troutman Sanders Tobacco Practice. Copyright 2014 Troutman Sanders LLP. All Rights Reserved.

Geographical Accuracy of Cell Phone Samples and the Effect on Telephone Survey Bias, Variance, and Cost

MetLife Foundation Alzheimer's Survey: What America Thinks

HIV in Prisons,

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview

DEPARTMENT OF DEFENSE (AFHSB)

Case 8:14-cv DKC Document 2-4 Filed 11/17/14 Page 1 of 17. Exhibit 3

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

Trends in Lung Cancer Morbidity and Mortality

AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well

Marijuana in the Workplace: The 411 on 420

September 20, Thomas Scully Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue SW Washington, DC 20201

NCQA did not add new measures to Accreditation 2017 scoring.

CMS Oral Health Ini9a9ve - Goals

2003 National Immunization Survey Public-Use Data File

HIV in Prisons, 2000

ROAD SAFETY MONITOR. ALCOHOL-IMPAIRED DRIVING IN THE UNITED STATES Results from the 2017 TIRF USA Road Safety Monitor

Public Health Federal Funding Request to Address the Opioid Epidemic

DEPARTMENT OF DEFENSE (AFHSB)

West Nile virus and other arboviral activity -- United States, 2016 Provisional data reported to ArboNET Tuesday, October 11, 2016

Recommendations for Re-Occupancy of Buildings Previously Used to Manufacture Methamphetamine

EMG Laws by State. needle EMGs and NCSs can be found in its position statement Who is Qualified to Practice EDX Medicine.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DEPARTMENT OF DEFENSE (AFHSB)

Cessation and Cessation Measures

NM Coalition of Sexual Assault Programs, Inc.

Piero Rinaldo, Si Houn Hahn, Dietrich Matern. Biochemical Genetics Laboratory Mayo Clinic College of Medicine Rochester, MN

DEPARTMENT OF DEFENSE (AFHSB)

Autism and Transition to Adulthood. Lorri Unumb, Esq. Vice President State Government Affairs Autism Speaks

March 5, The Honorable John A. Boehner Speaker U.S. House of Representatives H-232 U.S. Capitol Building Washington, DC 20515

B&T Format. New Measures. Better health care. Better choices. Better health.

Results from the Commonwealth Fund Scorecard on State Health System Performance. Douglas McCarthy. Senior Research Director The Commonwealth Fund

Exhibit 1. Change in State Health System Performance by Indicator

Perinatal Health in the Rural United States, 2005

Transcription:

SUMMARY OF SYNTHETIC CANNABINOID BILLS

Alabama: H.B. 163, S.B. 235, S.B. 283 indefinitely postponed as of 6/1/2011 - amends existing statute regarding chemical compounds to add JWH-200 and CP 47,497 Alaska: H.B. 7 passed 6/24/2011; effective 7/1/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol to its list of Schedule IIIA substances S.B. 17 no action since 2/25/2011 - adds JWH-028, JWH-073, JWH-200, CP 47,497 and its homologues to list of Schedule IIA substances Arizona: H.B. 2167 passed 2/28/2011; effective on passage - adds JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol to definition of dangerous drug and to list of Schedule I drugs Arkansas: S.B. 423 passed 3/28/2011; effective on date of approval by Governor - adds JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol to list of Schedule VI drugs California: S.B. 420 ordered to engrossing and enrolling as of 8/30/2011 - adds new statute for synthetic cannabinoids including JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol Colorado: S.B. 134 passed 6/2/2011; effective 7/1/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to definition of synthetic cannabinoids and adds two new penalty sections Connecticut: S.B. 761 no action since 1/25/2011 - amends general statutes to prohibit sale or possession of JWH-018, JWH-073, JWH-200 S.B. 1098 signed 7/8/2011; effective 7/1/2011 - directs the Commissioner of Consumer Protection to schedule JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol in the appropriate schedule H.B. 6079 no action since 1/25/2011 - amends general statutes to prohibit possession, use, sale or marketing of synthetic cannabis

S.B. 759 no action since 1/25/2011 - amends general statutes to prohibit the sale or possession of synthetic marijuana and provides for penalties Delaware: H.B. 30 passed 6/28/2011; effective on passage - adds definition of synthetic cannabinoid including JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues and schedules synthetic cannabinoids as Schedule I drugs Florida: H.B. 39 passed 5/31/2011; effective 7/1/2011 - adds JWH-018, JWH-073, JWH-200 and CP 47,497 to its list of Schedule I drugs and provides for penalties Georgia: S.B. 93 passed 5/13/2011; effective date of passage - adds JWH-200 to list of Schedule I drugs H.B. 199 passed Senate 3/30/2011; no action since - adds JWH-200 to its list of Schedule I drugs Hawaii: H.B. 1085 passed 6/6/2011; effective 7/1/2011 - adds JWH-018, JWH-073, CP 47,497 and cannabicyclohexanol to list of Schedule I drugs S.B. 1305 no action since 1/26/2011 - adds JWH-018, JWH-073, CP 47,497 and cannabicyclohexanol to list of Schedule I drugs Idaho: H.B. 139 passed 3/10/2011; effective on date of passage - adds generic language to Schedule I drugs H.B. 86 no action since 2/3/2011 - adds generic language to Schedule I drugs Illinois: H.B. 2917 passed 8/12/2011; effective 1/1/2012 - adds CP 47,497 and its homologues to list of Schedule I drugs H.B. 2595 passed 7/22/2011; effective 1/1/2012 - adds generic language to list of Schedule I substances H.B. 2089 passed 7/22/2011; effective on date of passage - adds CP 47,497 and its homologues to list of Schedule I substances

Indiana: S.B. 57 passed 5/10/2011; effective 7/1/2011 H.B. 1102 passed 5/10/2011; effective 7/1/2011 - penalizes possession and dealing of synthetic cannabinoids; adds new code section defining synthetic cannabinoids including JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues H.B. 1315 no action since 1/13/2011 S.B. 448 no action since 1/12/2011 H.B. 1277 no action since 1/12/2011 S.B. 5 no action since 1/5/2011 S.B. 152 no action since 1/5/2011 - penalize possession and dealing of synthetic cannabinoids; add new code sections defining synthetic cannabinoids including JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues without chemical designations Iowa: S.F. 510 passed 7/29/2011; effective retroactively to 7/1/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to Schedule I and provides penalties H.F. 186 passed House; referred to Senate committee 3/10/2011 - adds JWH-018, JWH-073, CP 47,497 and its homologues to list of Schedule I substances S.F. 462 passed Senate; message from House with amendment on 4/13/2011 H.F. 697 read first time in Senate and referred to committee as of 6/10/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to list of Schedule I substances and provides for penalties Kansas: H.B. 2049 passed 5/18/2011; effective 7/1/2011 - deletes JWH-018 and JWH-073 from list of Schedule I drugs and adds generic language to Schedule I; provides for penalties Kentucky: H.B. 121 passed 3/16/2011; effective upon passage - adds JWH-200 to definition of synthetic cannabinoid agonists or piperazines S.B. 129 no action since 2/10/2011 - adds JWH-200 to definition of synthetic cannabinoid agonists or piperazines Louisiana: H.B. 12 signed 7/13/2011; effective 7/15/2011 - adds generic language to Schedule I

Maine: H.P. 673 signed 7/6/2011; effective 7/1/2012 - adds JWH-018 and JWH-073 to Schedule Z drugs Massachusetts: H.B. 01383 no action since 1/24/2011 - adds definition of synthetic cannabinoid including JWH-018, JWH-073, CP 47,497 and its homologues and adds those substances to its list of Class D drugs H.B. 02133 no action since 1/24/2011 - bans K2 and spice and adds definition Minnesota: H.F. 57 passed 5/24/2011; effective 7/1/2011 - adds JWH-018, JWH-073, JWH-200 and CP 47,497 to list of Schedule I substances and provides penalties S.F. 7 no action since 1/10/2011 - adds JWH-018, JWH-073, JWH-200 and CP 47,497 to list of Schedule I substances S.F. 537 no action since 3/3/2011 - adds synthetic cannabinoids to definition of marijuana including JWH-018, JWH-073, JWH- 200 and CP 47,497 S.F. 850 no action since 3/16/2011 S.F. 1166 substituted by H.F. 57 in committee on 4/11/2011 - provides penalties for sale and possession of synthetic cannabinoids, including a definition of synthetic cannabinoids with JWH-018, JWH-073, JWH-200 and CP 47,497 Mississippi: H.B. 1205 passed 3/11/2011; effective on passage - adds generic language with JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues included to Schedule I and provides penalties Missouri: H.B. 641 signed 7/14/2011; effective 8/28/2011 - adds definition of synthetic cannabinoid and adds synthetic cannabinoids to list of Schedule I substances with generic language with JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues included Montana: H.B. 185 passed 4/8/2011; effective on passage - adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to list of Schedule I substances as well as generic language and provides penalties

Nebraska: L.B. 19 passed 2/22/2011; effective on passage - adds condensed version of generic language to Schedule I and provides penalties Nevada: S.B. 228 session adjourned; no further action allowed as of 4/16/2011 A.B. 339 session adjourned; no further action allowed as of 4/26/2011 - directs the State Board of Pharmacy to schedule JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol as Schedule I substances by October 1, 2011 New Hampshire: H.B. 448 no action since 3/9/2011 - adds definition of synthetic cannabinoid agonists or piperazines including JWH-018, JWH- 073, CP 47,497 and places them in Schedule I New Jersey: S.B. 2606 no action since 1/10/2011 A.B. 2644 no action since 5/13/2010 - adds JWH-018 and JWH-073 to Schedule I New Mexico: S.B. 134 passed 3/31/2011; effective on passage - adds JWH-018, JWH-073, JWH-200, CP 47,497, its homologues, and cannabicyclohexanol to Schedule I and provides penalties New York: S.B. 1834 passed Senate; referred to House committee 5/9/2011 A.B. 7231 referred to committee 4/19/2011 - prohibits the sale or distribution of JWH-018, JWH-073, CP 47,497 and its homologues A.B. 5008 no action since 2/10/2011 - adds JWH-018 and JWH-073 to list of Schedule I substances A.B. 7324 referred to committee 4/29/2011 - prohibits the sale or distribution of synthetic cannabinoids; includes a definition of synthetic cannabinoids which includes the generic language and trade names for JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol North Carolina: S.B. 7 passed 3/25/2011; effective 6/1/2011 - adds synthetic cannabinoids to Schedule VI drugs including the generic language with trade names for JWH-018, JWH-073, JWH-200, CP 47,497, its homologues, and cannabicyclohexanol and provides penalties

S.B. 4 no action since 1/27/2011 - adds generic language with trade names for JWH-018, JWH-073, JWH-200, CP 47,497, its homologues, and cannabicyclohexanol to Schedule I North Dakota: S.B. 2119 passed 4/19/2011; effective 8/1/2011 - adds generic language with trade names for JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol to Schedule I Ohio: S.B. 57 no action since 2/1/2011 - adds JWH-018 and JWH-073 to Schedule I H.B. 64 signed 7/15/2011; effective 91 days after filed with Secretary of State - adds JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol to Schedule I and provides penalties Oklahoma: S.B. 919 passed 5/13/2011; effective 11/1/2011 - adds JWH-018, JWH-073, JWH-200 and CP 47,497 to Schedule I Oregon: H.B. 2462 no action since 1/21/2011 H.B. 2709 no action since 2/4/2011 H.B. 3022 no action since 2/7/2011 - directs the Board of Pharmacy to schedule JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues as Schedule I substances Pennsylvania: S.B. 1006 passed 6/23/2011; effective 60 days from passage H.B. 365 passed House; referred to Senate committee 4/8/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to Schedule I H.B. 176 laid on the table 4/6/2011 - adds JWH-018, JWH-073, JWH-200 and CP 47,497 to Schedule I S.B. 164 no action since 1/19/2011 - adds JWH-018, JWH-073, CP 47,497 and its homologues to Schedule I Rhode Island: H.B. 5066 held for further study 3/1/2011 S.B. 869 no action since 4/14/2011 - adds Synthetic cannabinoids (synthetic marijuana) to Schedule I

South Carolina: S.B. 78 passed Senate; referred to House committee 4/13/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to Schedule I H.B. 3137 no action since 1/11/2011 H.B. 3144 no action since 1/11/2011 - adds JWH-018 and JWH-073 to Schedule I S.B. 374 no action since 1/18/2011 - creates new code section defining synthetic cannabinoids including JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol and providing penalties South Dakota: H.B. 1015 passed 2/25/2011; effective on passage - adds JWH-018, JWH-073, JWH-200 and CP 47,497 to list of Schedule I drugs Tennessee: H.B. 1889 passed 5/23/2011; effective 7/1/2011 - penalizes production, manufacture, distribution, possession or possession with intent to produce, manufacture, distribute synthetic substances, includes the generic language with trade names for JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues Texas: S.B. 331 passed 5/28/2011; effective 9/1/2011 - adds new code section for Penalty Group 2-A encompassing synthetic cannabinoids and including the generic language with trade names for JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues and providing for penalties Utah: H.B. 23 passed 2/25/2011; effective on passage - adds new code section listing JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues and providing for penalties Virginia: S.B. 745 passed 3/23/2011; effective on passage H.B. 1434 passed 3/23/2011; effective on passage - provides penalties for possession, sale, gift, distribution or possession with intent to sell, gift, or distribute JWH-018, JWH-073, JWH-200 and CP 47,497 Washington: H.B. 1285 reintroduced 4/26/2011 - adds definition of synthetic cannabinoids and adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to Schedule I

S.B. 5101 reintroduced 4/26/2011 S.B. 5954 referred to committee 5/3/2011 - adds generic language to Schedule I West Virginia: H.B. 2505 passed 4/5/2011; effective 30 days after passage - adds JWH-018, JWH-073, JWH-200, CP 47,497 and its homologues to Schedule I and provides penalties S.B. 63 no action since 2/3/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497, its homologues, and cannabicyclohexnol to Schedule I S.B. 276 no action since 1/26/2011 - adds definition of synthetic cannabinoids including JWH-018, JWH-073 and CP 47,497; adds synthetic cannabinoids to list of Schedule I substances Wisconsin: S.B. 54 passed 6/24/2011; effective 7/11/2011 A.B. 57 laid on the table 6/8/2011 - provides penalties and adds JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol to Schedule I Wyoming: H.B. 62 passed 2/18/2011; effective 7/1/2011 - adds JWH-018, JWH-073 and CP 47,497 to Schedule I S.F. 59 passed 3/3/2011; effective 7/1/2011 - adds CP 47,497 and version of generic language with JWH compounds as trade names to Schedule I United States Congress: US S605 placed on Senate legislative calendar under General Orders 7/29/2011 US HR1254 ordered reported as amended by voice vote 7/28/2011 - adds JWH-018, JWH-073, JWH-200, CP 47,497 and cannabicyclohexanol plus DEA generic language